Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Support for association of HSPG2 with tardive dyskinesia in Caucasian populations.

The pharmacogenomics journal - 1 Dec 2012

Greenbaum L, Alkelai A, Zozulinsky P, Kohn Y, Lerer B

Abstract excerpt

Tardive dyskinesia (TD) is a severe adverse effect of chronic antipsychotic drug treatment. In addition to clinical risk factors, TD susceptibility is influenced by genetic predisposition. Recently, Syu et al. (2010) reported a genome-wide association screening of TD in Japanese schizophrenia pat...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Genetic Associations and Epidemiology
Share to Genetic Predisposition to Disease
Share to Genomics and Rare Diseases

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Heparan Sulfate Proteoglycans

Share to Linkage Disequilibrium

Share to Movement Disorders

Share to Polymorphism, Single Nucleotide

Share to Schizophrenia research and treatment

Source

Identifiers

PMID: 21808285
DOI: 10.1038/tpj.2011.32

Genes

HSPG2

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026. Prepared record publication-21808285-2026-09-04.2. Manifest publication-graph-cohort-2026-09-04.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Support for association of HSPG2 with tardive dyskinesia in Caucasian populations.PMID 21808285Read ↗

Association of the HSPG2 gene with neuroleptic-induced tardive dyskinesia.Semantic proximity Read ↗

[Genome-wide association analyses for neuroleptic-induced tardive dyskinesia].Semantic proximity Read ↗

Evidence for association of the GLI2 gene with tardive dyskinesia in patients with chronic schizophrenia.Semantic proximity Read ↗

Genome Wide Study of Tardive Dyskinesia in SchizophreniaSemantic proximity Read ↗

Pharmacogenetics of tardive dyskinesia: an updated review of the literature.Semantic proximity Read ↗

Genome wide study of tardive dyskinesia in schizophrenia.Semantic proximity Read ↗

Glial cell line-derived neurotrophic factor receptor alpha 2 (GFRA2) gene is associated with tardive dyskinesia.Semantic proximity Read ↗

Genome-wide significant associations in schizophrenia to ITIH3/4, CACNA1C and SDCCAG8, and extensive replication of associations reported by the Schizophrenia PGC.Semantic proximity Read ↗

Genetic underpinnings of tardive dyskinesia: passing the baton to pharmacogenetics.Semantic proximity Read ↗

New insights into tardive dyskinesia genetics: Implementation of whole-exome sequencing approach.Semantic proximity Read ↗

CHRM2 and GRIN2A polymorphisms in tardive dyskinesia and cognitive impairments in Chinese Han schizophrenia.Semantic proximity Read ↗

GWA study data mining and independent replication identify cardiomyopathy-associated 5 (CMYA5) as a risk gene for schizophrenia.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.